Extracorporeal membrane oxygenation during the first three waves of the coronavirus disease 2019 pandemic: A retrospective single-center registry study.

Eugen WidmeierTobias WengenmayerSven MaierChristoph BenkViviane ZotzmannDawid L StaudacherAlexander Supady

Published in: Artificial organs (2022)

VV ECMO has shown to be a feasible and safe support option for patients with severe respiratory failure due to COVID-19. The results from this single-center study confirm findings from other cohorts showing declining survival rates of patients treated with VV ECMO during the COVID-19 pandemic, however, the specific reasons for this finding remain unclear.

Keyphrases

extracorporeal membrane oxygenation
coronavirus disease
respiratory failure
acute respiratory distress syndrome
sars cov
respiratory syndrome coronavirus
mechanical ventilation
early onset
intensive care unit
drug induced